The new BioSquare is the premiere bioconvergence partnering meeting for mature companies, high potential start-ups or willing investors working in the bioconvergence universe worldwide.

For the foreseeable future, health technologies will integrate developments from multiple disciplines — biotechnology, diagnostics, nanotechnology, medtech and in silico. This new ‘bioconvergence’ provides broader deal opportunities for pharmaceutical companies and investors. The challenge is to ensure that bioconvergence era players meet the right partners, face to face. Coming back in 2010, BioSquare will be held in Geneva and will be the first bioconvergence conference, with the support of BioAlps, the third European Life Sciences cluster. We expect well over 900 high level participants from medtech, biotech, pharma, diagnostics and nanotech companies worldwide to join us for 2 days of intense networking!

Come to BioSquare and

o Meet the members of BioAlps: over 500 research centers and 250 biotech, medtech, pharma and diagnostics companies located in the private banking capital of the world

o Panels: BioSquare’s conference track is entirely devoted to business development and innovation with few select keynote speeches and exciting speakers. Steven Burrill, CEO of Burrill & Co and a few CEOs from Top 10 pharma companies have already confirmed their participation!

o Company presentations: Present your organization, showcase your products, find investors!

o Expand your network: BioSquare will feature an “Innovation Corridor” dedicated to promising early stage projects. You’ll also have the opportunity to meet selected international delegations from Brazil, China, India, Russia and a few other fast-growing bioregions

o Sponsorships opportunities revisited: Fewer top level sponsorships, reduced brand building and some exciting new media-oriented opportunities including the BioSquare Media Channel

Come experience the new BioSquare and Accelerate your Partnering!